29 Apr 2010 09:02
e-Therapeutics plc
('e-Therapeutics' or 'the Company')
Issue of Equity and Director's award of Options
e-Therapeutics plc (AIM: ETX), the systems biology drug discovery company, announces that on 28 April 2010 , the Company issued and allotted 466,460 ordinary shares of 0.1p each in the Company (' Ordinary Shares') in order to satisfy the exercise of certain options.
Application has been made to admit the new Ordinary Shares to trading on AIM and dealings in the new Ordinary Shares are expected to commence on 5 May 2010. Following admission the number of Ordinary Shares in issue in the Company will be 65,886,752.
The above figure (65,886,752 Ordinary Shares) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, e-Therapeutics plc under the FSA's Disclosure and Transparency Rules.
In addition to the above, two directors of the Company being Mr Oliver James and Mr Brad Hoy were both granted option over 25,000 ordinary shares in the Company at an exercise price of £0.385 and which have a vesting period of 3 years. Following this grant Mr James and Mr Hoy have the following interests in ordinary shares of the Company:
| Name | Ordinary Shares owned | Options over Ordinary Shares | ||
|
| Number | Number | Exercise Price | Date at which exercisable |
| Oliver James | 38,500 | 118,020 | £0.67 | Vested |
|
|
| 25,000 | £0.385 | 28 April 2013 |
|
|
|
|
|
|
| Brad Hoy |
| 80,000 | £0.375 | Vested |
|
|
| 25,000 | £0.385 | 28 April 2013 |
- Ends -
| For more information: |
|
|
|
|
| e-Therapeutics plc | www.etherapeutics.co.uk |
| Malcolm Young malcolm@etherapeutics.co.uk | +44 (0) 191 233 1317 |
|
|
|
| Nominated Advisor & Broker: Canaccord Adams Ltd | www.canaccordadams.com |
| Robert Finlay / Henry Fitzgerald-O'Connor henry.fitzgerald-o'connor@canaccordadams.com | +44 (0) 20 7050 6500 |
|
|
|
|
|
|
| Media enquiries: Abchurch Communications | www.abchurch-group.com |
| Heather Salmond / Simone Elviss / Hannah Sharman simone.elviss@abchurch-group.com | +44 (0) 20 7398 7700
|